Russia will complete early-stage trials on a second potential COVID-19 vaccine, produced by the Vector Institute, on Sept. 30, the RIA news agency cited Russia's consumer health safety watchdog as saying on Monday.
The country announced last month that its first vaccine, named "Sputnik V" after the Soviet-era satellite that was the first launched into space in 1957, had already received approval.
This has raised concerns among Western scientists over a lack of safety data, with some warning that moving too quickly on a vaccine could be dangerous.
Russia has denounced such criticism as an attempt to undermine Moscow's research.
Please click to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the cookies used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan çerezlerle ilgili bilgi almak için lütfen tıklayınız.
